The Enterprise Value as of December 2025 (TTM) for Immix Biopharma, Inc. (IMMX) is 147.65M

According to Immix Biopharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 147.65M. This represents a change of 223.85% compared to the average of 45.59M of the last 4 quarters.

Immix Biopharma, Inc. (IMMX) Historical Enterprise Value (quarterly & annually)

How has IMMX Enterprise Value performed in the past?

The mean historical Enterprise Value of Immix Biopharma, Inc. over the last ten years is 40.41M. The current 147.65M Enterprise Value has changed 36.44% with respect to the historical average. Over the past ten years (40 quarters), IMMX's Enterprise Value was at its highest in in the December 2023 quarter at 120.35M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Immix Biopharma, Inc. (IMMX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Immix Biopharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Immix Biopharma, Inc. (IMMX) Average Enterprise Value

How has IMMX Enterprise Value performed in the past?

The current Enterprise Value of Immix Biopharma, Inc. (IMMX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Immix Biopharma, Inc. (IMMX) Enterprise Value vs. Peers

How is IMMX’s Enterprise Value compared to its peers?

Immix Biopharma, Inc.’s Enterprise Value is greater than Coya Therapeutics, Inc. (-29657635354.00), greater than Whitehawk Therapeutics Inc (-24287393.00), greater than Oncolytics Biotech Inc. (125.65M), greater than Zentalis Pharmaceuticals, Inc. (101.24M), greater than Surrozen, Inc. (73.38M), greater than Atossa Therapeutics, Inc. (40.25M), greater than Instil Bio, Inc. (69.60M), greater than Pliant Therapeutics, Inc. (16.18M), greater than MacroGenics, Inc. (44.18M), greater than Oramed Pharmaceuticals Inc. (98.45M),

Build a custom stock screener for Immix Biopharma, Inc. (IMMX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immix Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immix Biopharma, Inc. (IMMX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immix Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.